Skip to content
healthcare.dev

Olopatadine Hydrochloride Ophthalmic Solution

NDC 82442-967, Olopatadine Hydrochloride Ophthalmic Solution, solution, from TARGET CORPORATION.

Product NDC
82442-967
Status
Listed
Labeler
TARGET CORPORATION
Dosage form
SOLUTION
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA206087
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82442-967 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
82442-967-02824420967021 BOTTLE, PLASTIC in 1 CARTON (82442-967-02) / 3.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82442-967 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82442-967 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82442-967. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.